Supplementary Figure 15 from Baseline Tumor Features and Systemic Immune Dynamics Underlying Efficacy in MSS Metastatic Colorectal Cancer Treated with Regorafenib, Ipilimumab, and Nivolumab
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Figure 15. Expanded CD8+ T Cell TCR clonality analysis.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Colorectal Cancer Treatments and Studies
Genetic factors in colorectal cancer
Publication details
- Publication date
- 2 April 2026
- Language
- EN